Clinical Trial Update: A Study of the Effect of Dulaglutide on How the Body Handles Oral Contraceptive in Healthy Female Participants [Phase 1]

View source ↗

Summary

Phase 1 study to assess whether dulaglutide alters the metabolism of oral contraceptives in healthy female participants; completed with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• TRULICITY (DULAGLUTIDE)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED | Results posted: 2014-10-08